United Kingdom: green light for the vaccine against Covid-19 from the Franco-Austrian laboratory Valneva

The head office of the Valneva laboratory in Saint-Herblain in France (illustration image).

AP - David Vincent

Text by: RFI Follow

1 min

The Covid-19 vaccine from the Franco-Austrian laboratory Valneva has been approved in the United Kingdom, the British regulator, the MHRA, said on Thursday April 14.


Read more

The Covid-19 vaccine developed by Valneva today received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA)

,” the agency said in a statement saying the regulator British is the first in the world to approve it.

The #Valneva Covid-19 vaccine has been approved for use.

This is the sixth COVID-19 vaccine to be granted an MHRA authorization.

Our decision follows a rigorous review of the safety, quality and effectiveness.

Find out more: https://t.co/I9GV8NU0iM pic.twitter.com/Ta8KULI6FA

— MHRAgovuk (@MHRAgovuk) April 14, 2022

Valneva had already received authorization for the emergency use of its serum from the Kingdom of Bahrain, which bought a million doses from it.

The laboratory has also signed

an agreement with the European Commission 

for the supply of a maximum of 60 million doses over two years in 2022 and 2023.

Valneva is the sixth coronavirus


to be licensed in the UK, joining those from AstraZeneca, Pfizer, Moderna, the single-dose Janssen (Johnson & Johnson) and Novavax.

 The Independent Commission for Medicinal Products for Human Use and its expert task force on Covid-19 have carefully reviewed the available evidence and (…) the benefit/risk ratio is positive

,” said Professor Munir Pirmohamed, chairman of this commission, quoted in this press release.

The Valneva vaccine can be used in people aged 18 to 50, with the first and second doses taken at least 28 days apart.

This vaccine can be stored at the temperature of conventional refrigerators, which facilitates its use.

The UK has been hit hard by the coronavirus pandemic which has claimed more than 171,000 lives there.

More than 92% of the population aged 12 and over received a first dose of the Covid-19 vaccine, 86.2% a second dose and 67.8% a booster dose.

(with AFP) 


Receive all the international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application


  • UK

  • Vaccines

  • Coronavirus

  • France

  • Austria